Psyence Biomedical Ltd. (PBMWW)Toronto, Canada | NasdaqCM
0.02 USD
|
Hot Take ↕ | Oct. 10, 2026, 4:33 a.m. EDT
The security is trapped in a death spiral where the price has collapsed to a fraction of its book value, signaling a catastrophic failure in market valuation. Fundamentally, the company is bleeding cash aggressively with negative operating and free cash flows, while returning equity to shareholders via massive dilution rather than dividends. The recent news confirms this distress with a drastic reverse stock split and a sharp price slide, indicating that even speculative capital is fleeing. With no price history available to assess long-term trends and a complete lack of dividend payments, there is no safety margin or recovery catalyst visible in the data. |
| Attribute | Value |
|---|---|
| Beta | 1.69 |
| Previous Name | Psyence Therapeutics Corp. |
| Website | https://psyencebiomed.com |
| Attribute | Value |
|---|---|
| Address1 | 121 Richmond Street West |
| Address2 | Penthouse Suite 1300 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.686 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 7.389 |
| City | Toronto |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0161 |
| Current Ratio | 14.619 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.023 |
| Day Low | 0.016 |
| Ebitda | -6,232,245 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.023 |
| Fifty Two Week High Change | -0.0068999995 |
| Fifty Two Week High Change Percent | -0.29999998 |
| Fifty Two Week Low | 0.016 |
| Fifty Two Week Low Change | 0.00009999983 |
| Fifty Two Week Low Change Percent | 0.006249989 |
| Fifty Two Week Range | 0.016 - 0.023 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 2,605,033 |
| Free Cashflow | -4,955,898 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Fullday Change | 0.0 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 0.0161 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,024-01-26 |
| Language | en-US |
| Long Business Summary | Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc. |
| Long Name | Psyence Biomedical Ltd. |
| Market | us_market |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_698500412 |
| Name Change Date | 2,026-10-16 |
| Net Income To Common | -6,936,421 |
| Open | 0.024 |
| Operating Cashflow | -8,143,007 |
| Operating Margins | 0.0 |
| Phone | 416-477-1708 |
| Prev Name | Psyence Therapeutics Corp. |
| Previous Close | 0.0161 |
| Price Hint | 4 |
| Price To Book | 0.0021789146 |
| Profit Margins | 0.0 |
| Quick Ratio | 12.122 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 0.023 |
| Regular Market Day Low | 0.016 |
| Regular Market Day Range | 0.016 - 0.023 |
| Regular Market Open | 0.024 |
| Regular Market Previous Close | 0.0161 |
| Regular Market Price | 0.0161 |
| Regular Market Time | 1,792,005,661 |
| Regular Market Volume | 1,534 |
| Return On Assets | -0.31333 |
| Return On Equity | -0.58619 |
| Sand P52 Week Change | 0.16207206 |
| Sector | |
| Sector Key | |
| Short Name | Psyence Biomedical Ltd. Warrant |
| Source Interval | 15 |
| State | ON |
| Symbol | PBMWW |
| Total Cash | 7,444,763 |
| Total Cash Per Share | 1.952 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 1,534 |
| Website | https://psyencebiomed.com |
| Zip | M5H 2K1 |